Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on mild synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104761582A details a mild route for Sofosbuvir intermediates ensuring high purity and scalable manufacturing for global supply chain reliability.
Novel mild temperature process for high-purity Valnemulin. Eliminates chromatography, reducing costs for antibiotic manufacturers.
Discover a cost-effective, high-yield synthesis for Sacubitril intermediates with >99% purity and >98% ee, eliminating isomer impurities and supply chain risks.
Solve low yield and environmental issues in bis(3-amino-4-hydroxyphenyl)hexafluoropropane production. Our CDMO expertise delivers high-purity, scalable synthesis for aerospace and pharmaceutical applications.
Solve PF-07321332 synthesis challenges: 76%+ yield, 98% purity, mild conditions. Eliminate -78°C steps & column chromatography. Scale to 100MT/yr.
Discover a novel, high-yield synthesis method for spiro[indene-isoindolinone] compounds with mild reaction conditions. Ideal for pharmaceutical R&D and production, reducing costs and safety risks.
Discover how enaminone synthesis with mild conditions and high yields solves supply chain risks for pharma intermediates. Reduce costs and scale efficiently.
Discover a novel, scalable synthesis method for azidoalkylthio olefin derivatives with 45-90% yield, reducing production costs and safety risks in drug development.
Discover a metal-free, high-yield method for chiral 1,3-diamine with >97:3 dr. Reduce costs and supply chain risks in pharmaceutical synthesis.
Solve harsh reaction conditions and poor functional group tolerance in trifluoromethyl heterocycle synthesis. Our CDMO expertise ensures scalable, high-purity production for pharma intermediates.
Solve low-yield BDT synthesis challenges with 91% yield, easy purification, and scalable copper-catalyzed process. Reduce R&D costs and supply chain risks.
Discover how emerging bimatoprost synthesis methods reduce costs by 25% with 85%+ yields. Solve supply chain risks for glaucoma treatments and eyelash growth applications.